Helmet NIV in Acute Hypoxemic Respiratory Failure due to COVID-19: Change in PaO/FiO Ratio a Predictor of Success.

Indian J Crit Care Med

Department of Pulmonology and Critical Care, Fortis Hospital, Noida, Uttar Pradesh, India.

Published: October 2021

In acute respiratory failure due to severe coronavirus disease 2019 (COVID-19) pneumonia, mechanical ventilation remains challenging and may result in high mortality. The use of noninvasive ventilation (NIV) may delay required invasive ventilation, increase adverse outcomes, and have a potential aerosol risk to caregivers. Data of 30 patients were collected from patient files and analyzed. Twenty-one (70%) patients were weaned successfully after helmet-NIV support (NIV success group), and invasive mechanical ventilation was required in 9 (30%) patients (NIV failure group) of which 8 (26.7%) patients died. In NIV success vs failure patients, the mean baseline PaO/FiO ratio (PFR) (147.2 ± 57.9 vs 156.8 ± 59.0 mm Hg; = 0.683) and PFR before initiation of helmet (132.3 ± 46.9 vs 121.6 ± 32.7 mm Hg; = 0.541) were comparable. The NIV success group demonstrated a progressive improvement in PFR in comparison with the failure group at 2 hours (158.8 ± 56.1 vs 118.7 ± 40.7 mm Hg; = 0.063) and 24 hours (PFR-24) (204.4 ± 94.3 vs 121.3 ± 32.6; = 0.016). As predictor variables, PFR-24 and change (delta) in PFR at 24 hours from baseline or helmet initiation (dPFR-24) were significantly associated with NIV success in univariate analysis but similar significance could not be reflected in multivariate analysis perhaps due to a small sample size of the study. The PFR-24 cutoff of 161 mm Hg and dPFR-24 cutoff of -1.44 mm Hg discriminate NIV success and failure groups with the area under curve (confidence interval) of 0.78 (0.62-0.95); = 0.015 and 0.74 (0.55-0.93); = 0.039, respectively. Helmet interface NIV may be a safe and effective tool for the management of patients with severe COVID-19 pneumonia with acute respiratory failure. More studies are needed to further evaluate the role of helmet NIV especially in patients with initial PFR <150 mm Hg to define PFR/dPFR cutoff at the earliest time point for prediction of helmet-NIV success. Jha OK, Kumar S, Mehra S, Sircar M, Gupta R Helmet NIV in Acute Hypoxemic Respiratory Failure due to COVID-19: Change in PaO/FiO Ratio a Predictor of Success. Indian J Crit Care Med 2021;25(10):1137-1146.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645804PMC
http://dx.doi.org/10.5005/jp-journals-10071-23992DOI Listing

Publication Analysis

Top Keywords

niv success
20
respiratory failure
12
niv
9
helmet niv
8
pao/fio ratio
8
acute respiratory
8
covid-19 pneumonia
8
mechanical ventilation
8
success group
8
failure group
8

Similar Publications

Background: High-flow nasal cannula (HFNC) therapy has developed as a valuable tool for respiratory support in pediatric critical care. It offers an intermediate level of support between traditional low-flow oxygen and non-invasive ventilation (NIV). Studies suggest its effectiveness in improving oxygen delivery, work of breathing, and secretion clearance.

View Article and Find Full Text PDF

Efficacy and safety of nasal high-frequency oscillation in preventing intubation in very-low-birth-weight infants with respiratory distress syndrome.

Pediatr Neonatol

December 2024

Department of Pediatrics, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, 217 Hong Bang Street District 5, Ho Chi Minh City, 700000, Viet Nam; University Medical Center Ho Chi Minh City, 215 Hong Bang Street District 5, Ho Chi Minh City, 700000, Viet Nam; Neonatal Intensive Care Unit, Children's Hospital 2, 14 Ly Tu Trong Street District 1, Ho Chi Minh City, 700000, Viet Nam. Electronic address:

Background: Invasive mechanical ventilation in very-low-birth-weight infants (VLBWI) was associated with immediate and long-term complications. Nasal high-frequency oscillation (nHFO) has recently become a new non-invasive ventilation (NIV) mode for treating respiratory failure in VLBWI. This study aimed to investigate the safety and efficacy of nHFO as an alternative respiratory support to prevent intubation in VLBWI.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to identify factors influencing CPAP failure rates in patients with COVID-19-related hypoxemia, analyzing 200 ICU patients in southwestern Iran.
  • Results showed a high CPAP failure rate (78.5%), particularly linked to higher HACOR scores, diabetes mellitus, older age, obesity, and elevated Blood Urea Nitrogen levels.
  • The findings suggest that specific clinical factors such as HACOR scores and comorbidities significantly impact the effectiveness of CPAP therapy in these patients.
View Article and Find Full Text PDF

Background And Aims: Even though patient tolerance is critical to the success of noninvasive ventilation (NIV), research on using sedation to improve tolerance to NIV after traumatic chest injuries is limited. We hypothesized that dexmedetomidine would be superior to ketamine in terms of patient tolerance and lengthening the NIV sessions after blunt chest trauma.

Material And Methods: This randomized, double-blinded, placebo-controlled trial included 45 patients of both genders aged 18-60 who needed NIV after blunt chest trauma.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!